Diagnosis of bile acid diarrhoea by fasting and postprandial measurements of fibroblast growth factor 19

European Journal of Gastroenterology and Hepatology

Volumn 27, Issue 12, 2015, Pages 1399-1402

  Borup, Christian ^a   Syversen, Charlotte ^a   Bouchelouche, Pierre ^a   Damgaard, Morten ^a   Graff, Jesper ^b   Rumessen, Jüri Johannes ^c   Munck, Lars Kristian ^a,d  

^a KØGE HOSPITAL   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Bile acids and salts; diarrhoea; fibroblast growth factors; malabsorption syndromes

Indexed keywords

BILE ACID; FIBROBLAST GROWTH FACTOR 19; BIOLOGICAL MARKER; FGF19 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR;

ADULT; ARTICLE; BILE ACID DIARRHEA; BLOOD SAMPLING; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIARRHEA; DIET RESTRICTION; FASTING FIBROBLAST GROWTH FACTOR 19 BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTPARANDIAL FIBROBLAST GROWTH FACTOR 19 BLOOD LEVEL; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPRODUCIBILITY; AGED; BLOOD; CHRONIC DISEASE; EVALUATION STUDY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY;

ADULT; AGED; BILE ACIDS AND SALTS; BIOMARKERS; CHRONIC DISEASE; DIARRHEA; FASTING; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 84947027115     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000476     Document Type: Article

References (19)

1. Hofmann AF. Chronic diarrhea caused by idiopathic bile acid malab-sorption: an explanation at last. Expert Rev Gastroenterol Hepatol 2009; 3:461-464.
2. Walters JR. Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder. Expert Rev Gastroenterol Hepatol 2010; 4:561-567.
3. Gracie DJ, Kane JS, Mumtaz S, Scarsbrook AF, Chowdhury FU, Ford AC. Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea. Neurogastroenterol Motil 2012; 24:983-e538.
4. Wildt S, Norby Rasmussen S, Lysgard Madsen J, Rumessen JJ. Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test. Scand J Gastroenterol 2003; 38:826-830.
5. Vijayvargiya P, Camilleri M, Shin A, Saenger A. Methods for diagnosis of bile acid malabsorption in clinical practice. Clin Gastroenterol Hepatol 2013; 11:1232-1239.
6. Bajor A, Tornblom H, Rudling M, Ung KA, Simrén M. Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS. Gut 2015; 64:84-92.
7. Wedlake L, A'Hern R, Russell D, Thomas K, Walters JR, Andreyev HJ. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoeapredominant irritable bowel syndrome. Aliment Pharmacol Ther 2009; 30:707-717.
8. Kurien M, Evans KE, Leeds JS, Hopper AD, Harris A, Sanders DS. Bile acid malabsorption: an under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms. Scand J Gastroenterol 2011; 46:818-822.
9. Walters JR, Pattni SS. Managing bile acid diarrhoea. Therap Adv Gastroenterol 2010; 3:349-357.
10. Wilcox C, Turner J, Green J. Systematic review: the management of chronic diarrhoea due to bile acid malabsorption. Aliment Pharmacol Ther 2014; 39:923-939.
11. Borghede MK, Schlutter JM, Agnholt JS, Christensen LA, Gormsen LC, Dahlerup JF. Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea. Eur J Intern Med 2011; 22:e137-e140.
12. Pattni SS, Brydon WG, Dew T, Walters JR. Fibroblast growth factor 19 and 7alpha-hydroxy-4-cholesten-3-one in the diagnosis of patients with possible bile acid diarrhea. Clin Transl Gastroenterol 2012; 3:e18.
13. Pattni SS, Brydon WG, Dew T, Johnston IM, Nolan JD, Srinivas M, et al. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention. Aliment Pharmacol Ther 2013; 38:967-976.
14. Zweers SJ, Booij KA, Komuta M, Roskams T, Gouma DJ, Jansen PL, et al. The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract. Hepatology 2012; 55:575-583.
15. Lundåsen T, Galman C, Angelin B, Rudling M. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med 2006; 260:530-536.
16. Morton GJ, Kaiyala KJ, Foster-Schubert KE, Cummings DE, Schwartz MW. Carbohydrate feeding dissociates the postprandial FGF19 response from circulating bile acid levels in humans. J Clin Endocrinol Metab 2014; 99:E241-E245.
17. Jørgensen NB, Dirksen C, Bojsen-Møller KN, Kristiansen VB, Wulff BS, Rainteau D, et al. Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations. J Clin Endocrinol Metab 2015; 100:E396-E406.
18. Walters JR, Johnston IM, Nolan JD, Vassie C, Pruzanski ME, Shapiro DA. The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid. Aliment Pharmacol Ther 2015; 41:54-64.
19. Zhang JH, Nolan JD, Kennie SL, Johnston IM, Dew T, Dixon PH, et al. Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids. Am J Physiol Gastrointest Liver Physiol 2013; 304:G940-G948.